Retour
26
32
39
51
39
25
35
Fourchette du Jour
91,00 €
93,83 €
Fourchette 52 Semaines
53,56 €
112,29 €
Volume
998 863
Moyenne 50J / 200J
100,52 €
/
89,67 €
Clôture Précédente
90,62 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 14,3 | 0,2 |
| P/B | 3,6 | 3,0 |
| ROE % | 29,9 | 3,6 |
| Net Margin % | 25,0 | 3,8 |
| Rev Growth 5Y % | 14,6 | 9,9 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
108,90 €
+18.1%
Low: 84,00 €
High: 135,00 €
P/E Prévisionnel
12,30
BPA Prévisionnel
7,50 €
Croissance BPA (est.)
+0,0%
CA Est.
5,60B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,03 €
3,79 € – 4,69 €
|
4,74B | 4 |
| FY2029 |
3,52 €
3,31 € – 4,09 €
|
4,59B | 4 |
| FY2028 |
9,60 €
6,20 € – 12,73 €
|
6,48B | 11 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | 1,90 € | 1,80 € | -5,3% |
| 2025-10-28 | 1,66 € | 2,26 € | +36,1% |
| 2025-07-29 | 1,39 € | 1,57 € | +12,9% |
| 2025-04-29 | 1,01 € | 1,16 € | +14,9% |
| 2025-02-10 | 1,57 € | 1,43 € | -8,9% |
| 2024-10-29 | 1,12 € | 1,07 € | -4,5% |
| 2024-07-30 | 0,78 € | -1,82 € | -333,3% |
| 2024-04-30 | 0,84 € | 0,64 € | -23,8% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 14,55% annually over 5 years — strong growth
Earnings grew 3844,96% over the past year
ROE of 29,87% indicates high profitability
Net margin of 25,03% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 1,35B in free cash flow
Croissance
Revenue Growth (5Y)
14,55%
Revenue (1Y)21,22%
Earnings (1Y)3844,96%
FCF Growth (3Y)73,69%
Qualité
Return on Equity
29,87%
ROIC19,23%
Net Margin25,03%
Op. Margin26,12%
Sécurité
Debt / Equity
0,01
Current Ratio3,32
Interest Coverage553,03
Valorisation
P/E Ratio
14,27
Forward P/E12,30
P/B Ratio3,55
EV/EBITDA11,41
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21,22% | Revenue Growth (3Y) | 17,95% |
| Earnings Growth (1Y) | 3844,96% | Earnings Growth (3Y) | 46,73% |
| Revenue Growth (5Y) | 14,55% | Earnings Growth (5Y) | 7,92% |
| Profitability | |||
| Revenue (TTM) | 5,14B | Net Income (TTM) | 1,29B |
| ROE | 29,87% | ROA | 18,49% |
| Gross Margin | 91,47% | Operating Margin | 26,12% |
| Net Margin | 25,03% | Free Cash Flow (TTM) | 1,35B |
| ROIC | 19,23% | FCF Growth (3Y) | 73,69% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 3,32 |
| Interest Coverage | 553,03 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 14,27 | Forward P/E | 12,30 |
| P/B Ratio | 3,55 | P/S Ratio | 3,57 |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | 11,41 | Fwd EV/EBITDA | 12,74 |
| Forward P/S | 3,28 | Fwd Earnings Yield | 8,13% |
| FCF Yield | 7,38% | ||
| Market Cap | 18,36B | Enterprise Value | 15,33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,14B | 4,24B | 3,70B | 3,39B | 2,99B |
| Net Income | 1,29B | 32,62M | 597,60M | 340,66M | 948,58M |
| EPS (Diluted) | 6,41 | 0,15 | 2,65 | 1,52 | 4,27 |
| Gross Profit | 4,70B | 3,86B | 3,38B | 3,14B | 2,80B |
| Operating Income | 1,34B | 80,14M | 651,77M | 599,56M | 637,54M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,96B | 5,44B | 6,78B | 5,84B | 4,93B |
| Total Liabilities | 1,80B | 2,00B | 1,59B | 1,47B | 1,16B |
| Shareholders' Equity | 5,17B | 3,45B | 5,19B | 4,37B | 3,77B |
| Total Debt | 69,43M | 43,54M | 38,29M | 41,46M | 44,82M |
| Cash & Equivalents | 3,10B | 1,69B | 3,21B | 2,95B | 2,06B |
| Current Assets | 5,02B | 3,24B | 4,65B | 4,09B | 3,12B |
| Current Liabilities | 1,52B | 1,64B | 1,24B | 1,16B | 854,31M |
Scores de Stratégies
This stock passed the criteria for 7 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#899 of 1049
Custom
Capital Light Compounder
#149 of 220
#124 of 158
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#169 of 327
#84 of 203
Custom
Balanced Risk
#149 of 153
Custom
Lower Risk
#119 of 141
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Growth Investing (Philip Fisher)
Mar 24, 2026
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Entré
Value Investing (Warren Buffett)
Mar 24, 2026
Entré
Balanced Risk
Mar 24, 2026
Entré
Lower Risk
Mar 24, 2026